Literature DB >> 30796007

Overview of the cholinergic contribution to gait, balance and falls in Parkinson's disease.

Rosie Morris1, Douglas N Martini1, Tara Madhyastha2, Valerie E Kelly3, Thomas J Grabowski2, John Nutt1, Fay Horak4.   

Abstract

Mobility deficits, including gait disturbance, balance impairments and falls, are common features of Parkinson's disease (PD) that negatively impact quality of life. Mobility deficits respond poorly to dopaminergic medications, indicating a role for additional neurotransmitters. Due to the critical role of cortical input to gait and balance, acetylcholine-an essential neurotransmitter system for attention-has become an area of interest for mobility. This review aimed to identify the role of cholinergic function on gait, balance, and falls in PD using three techniques; pharmacological, imaging, and electrophysiological. Studies supported the role of the cholinergic system for mobility in PD, with the most promising evidence indicating a role in falls. Imaging studies demonstrated involvement of anterior cholinergic (basal forebrain) systems in gait, and posterior (brainstem) systems in balance. However, this review identified a small number of studies which used varying protocols, making comparisons difficult. Further studies are warranted, measuring comprehensive gait and balance characteristics as well as gold standard falls detection to further quantify the relationship between ACh and mobility in PD.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Acetylcholine; Balance; Falls; Gait; Parkinson's disease

Mesh:

Substances:

Year:  2019        PMID: 30796007      PMCID: PMC6682416          DOI: 10.1016/j.parkreldis.2019.02.017

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  62 in total

Review 1.  A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance.

Authors:  Paolo Calabresi; Barbara Picconi; Lucilla Parnetti; Massimiliano Di Filippo
Journal:  Lancet Neurol       Date:  2006-11       Impact factor: 44.182

Review 2.  Gait and cognition: Mapping the global and discrete relationships in ageing and neurodegenerative disease.

Authors:  Rosie Morris; Sue Lord; Jennifer Bunce; David Burn; Lynn Rochester
Journal:  Neurosci Biobehav Rev       Date:  2016-02-23       Impact factor: 8.989

3.  Role of body-worn movement monitor technology for balance and gait rehabilitation.

Authors:  Fay Horak; Laurie King; Martina Mancini
Journal:  Phys Ther       Date:  2014-12-11

4.  Independent domains of gait in older adults and associated motor and nonmotor attributes: validation of a factor analysis approach.

Authors:  Sue Lord; Brook Galna; Joe Verghese; Shirley Coleman; David Burn; Lynn Rochester
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-12-18       Impact factor: 6.053

5.  Predicting first fall in newly diagnosed Parkinson's disease: Insights from a fall-naïve cohort.

Authors:  Sue Lord; Brook Galna; Alison J Yarnall; Shirley Coleman; David Burn; Lynn Rochester
Journal:  Mov Disord       Date:  2016-09-13       Impact factor: 10.338

Review 6.  Medical Management of Parkinson's Disease after Initiation of Deep Brain Stimulation.

Authors:  Alfonso Fasano; Silke Appel-Cresswell; Mandar Jog; Mateusz Zurowkski; Sarah Duff-Canning; Melanie Cohn; Marina Picillo; Christopher R Honey; Michel Panisset; Renato Puppi Munhoz
Journal:  Can J Neurol Sci       Date:  2016-09       Impact factor: 2.104

7.  Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease.

Authors:  V Di Lazzaro; A Oliviero; F Pilato; E Saturno; M Dileone; C Marra; A Daniele; S Ghirlanda; G Gainotti; P A Tonali
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

Review 8.  What Can Quantitative Gait Analysis Tell Us about Dementia and Its Subtypes? A Structured Review.

Authors:  Ríona Mc Ardle; Rosie Morris; Joanna Wilson; Brook Galna; Alan J Thomas; Lynn Rochester
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  The relationship between real world ambulatory activity and falls in incident Parkinson's disease: influence of classification scheme.

Authors:  Karen Mactier; Sue Lord; Alan Godfrey; David Burn; Lynn Rochester
Journal:  Parkinsonism Relat Disord       Date:  2014-12-24       Impact factor: 4.891

10.  A review of dual-task walking deficits in people with Parkinson's disease: motor and cognitive contributions, mechanisms, and clinical implications.

Authors:  Valerie E Kelly; Alexis J Eusterbrock; Anne Shumway-Cook
Journal:  Parkinsons Dis       Date:  2011-10-27
View more
  16 in total

1.  Cholinergic nucleus 4 atrophy and gait impairment in Parkinson's disease.

Authors:  W Alex Dalrymple; Diane S Huss; Jamie Blair; Joseph L Flanigan; James Patrie; Scott A Sperling; Binit B Shah; Madaline B Harrison; T Jason Druzgal; Matthew J Barrett
Journal:  J Neurol       Date:  2020-07-28       Impact factor: 4.849

2.  Frequency of and risk factors for potentially inappropriate medication use in Parkinson's disease.

Authors:  Danielle S Abraham; Thanh Phuong Pham Nguyen; Sean Hennessy; Daniel Weintraub; Shelly L Gray; Dawei Xie; Allison W Willis
Journal:  Age Ageing       Date:  2020-08-24       Impact factor: 10.668

3.  Relationships Between Sensorimotor Inhibition and Mobility in Older Adults With and Without Parkinson's Disease.

Authors:  Douglas N Martini; Rosie Morris; Tara M Madhyastha; Thomas J Grabowski; John Oakley; Shu-Ching Hu; Cyrus P Zabetian; Karen L Edwards; Amie Hiller; Kathryn Chung; Katrina Ramsey; Jodi A Lapidus; Brenna Cholerton; Thomas J Montine; Joseph F Quinn; Fay B Horak
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-03-31       Impact factor: 6.053

4.  Anticholinergic Medication Use, Dopaminergic Genotype, and Recurrent Falls.

Authors:  Andrea L Rosso; Zachary A Marcum; Xiaonan Zhu; Nicolaas Bohnen; Caterina Rosano
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-05-05       Impact factor: 6.591

Review 5.  Interventions to improve gait in Parkinson's disease: a systematic review of randomized controlled trials and network meta-analysis.

Authors:  Victor Schwartz Hvingelby; Andreas Nørgaard Glud; Jens Christian Hedemann Sørensen; Yen Tai; Anne Sofie Møller Andersen; Erik Johnsen; Elena Moro; Nicola Pavese
Journal:  J Neurol       Date:  2022-04-05       Impact factor: 6.682

6.  Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease.

Authors:  Danielle S Abraham; Thanh Phuong Pham Nguyen; Sean Hennessy; Shelly L Gray; Dawei Xie; Daniel Weintraub; Allison W Willis
Journal:  Am J Geriatr Psychiatry       Date:  2020-05-18       Impact factor: 4.105

7.  α4β2* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait-Balance Disorders.

Authors:  Roger L Albin; Martijn L T M Müller; Nicolaas I Bohnen; Cathie Spino; Martin Sarter; Robert A Koeppe; Ashley Szpara; Kamin Kim; Cindy Lustig; William T Dauer
Journal:  Ann Neurol       Date:  2021-05-26       Impact factor: 11.274

8.  Cholinergic Markers and Cytokines in OSA Patients.

Authors:  Marcella Reale; Lucia Velluto; Marta Di Nicola; Chiara D'Angelo; Erica Costantini; Michele Marchioni; Gianluigi Cerroni; Biancamaria Guarnieri
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923

Review 9.  Psychosis in Parkinson's disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges.

Authors:  John L Waddington
Journal:  Acta Pharmacol Sin       Date:  2020-03-05       Impact factor: 6.150

Review 10.  An Update on Medical and Surgical Treatments of Parkinson's Disease.

Authors:  Dipali Nemade; Thyagarajan Subramanian; Vikram Shivkumar
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.